CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

    Related Conference of CRISPR Based Technologies and Bio-products

    December 07-08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 09-09, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 21-21, 2020

    Genetics and Molecular biology

    Paris, France

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in